| Literature DB >> 18041582 |
Reza M Salek1, Rebecca E Colebrooke, Robin Macintosh, Patrick J Lynch, Brian C Sweatman, Piers C Emson, Julian L Griffin.
Abstract
The vesicular monoamine transporter 2 (VMAT2) sequesters monoamines into synaptic vesicles in preparation for neurotransmission. Samples of cerebellum, cortex, hippocampus, substantia nigra and striatum from VMAT2-deficient mice were compared to age-matched control mice. Multivariate statistical analyses of (1)H NMR spectral profiles separated VMAT2-deficient mice from controls for all five brain regions. Although the data show that metabolic alterations are region- and age-specific, in general, analyses indicated decreases in the concentrations of taurine and creatine/phosphocreatine and increases in glutamate and N-acetyl aspartate in VMAT2-deficient mouse brain tissues. This study demonstrates the efficacy of metabolomics as a functional genomics phenotyping tool for mouse models of neurological disorders, and indicates that mild reductions in the expression of VMAT2 affect normal brain metabolism.Entities:
Mesh:
Substances:
Year: 2007 PMID: 18041582 DOI: 10.1007/s11064-007-9542-3
Source DB: PubMed Journal: Neurochem Res ISSN: 0364-3190 Impact factor: 3.996